跳到正文
原文
Adam Feuerstein ✡️· @adamfeuerstein · X·· 11 天前AI 评分20
AI 导读

在$ABOS失败之后,我重新审视了$PMN的阿尔茨海默病药物。这两款药物之间是否存在差异,可能让ProMIS在其研究于2027年Q1读出结果时获得更积极的结果? 我再次借助Mindgram的AI智能体来解析这两款药物并做出预测。 https://www.statnews.com/2026/11/05/promis-neurosciences-alzheimers-disease-acumen-vertex-kidney-drug/

正文

I took another look at the $PMN Alzheimer's drug in the wake of the $ABOS failure. Are there differences between the two drugs that might yield a more positive result for ProMIS when its study reads out in Q1 '27?

Once again, I turned to Mindgram's AI agent to parse the drugs and make a prediction.

https://www.statnews.com/2026/11/05/promis-neurosciences-alzheimers-disease-acumen-vertex-kidney-drug/

来源:Adam Feuerstein ✡️ · x.com